BAFTA confirms new and returning chairs and deputy chairs of its Film and Television Committees

Jul 27, 2023 | Business

WEBWIRE –

BAFTA today confirms the chairs and deputy chairs of its Film and Television Committees.

BAFTAs three sector committees comprised of BAFTA members who volunteer their time play a central role in the oversight and steering of BAFTAs high-profile Film, Games and Television Awards, and support BAFTA to deliver its strategic charitable mission through invaluable industry insight and expertise. The chairs of all three committees also sit on BAFTAs Board of Trustees.

BAFTAs guiding principles for its awards are to celebrate creative excellence, level the playing field, provide a fair and robust process, and encourage positive industry change. The eligibility, campaigning rules and voting criteria for the Film, Games, Television and Television Craft Awards are individually reviewed and set by the sector committees annually.

  • Anna Higgs, managing director of Casarotto Ramsay & Associates, has been re-elected as chair of BAFTAs Film Committee, having held the position of chair for the previous two years, and deputy chair two years prior. Anna will serve alongside Emily Stillman, senior vice president at Warner Bros. Studio Leavesden, who has been newly elected deputy chair.
  • Hilary Rosen, director of commissioning at UKTV, has been newly elected as chair of BAFTAs Television Committee. Christine Healy, COO of Keshet Productions UK, has been newly elected deputy chair.

As previously announced, Sara Putt was recently appointed by the Board as chair of BAFTA in June 2023. Tara Saunders continues as chair of the Games Committee, alongside deputy chair Des Gayle.

Sara Putt, chair of BAFTA said: We are so grateful to our Sector Committee members who are comprised of people from across the screen industries who generously volunteer their time and expertise. We are delighted to see Anna Higgs re-elected as our Film Committee chair, and to welcome Hilary Rosen to the chair of the Television Committee for the first time. Together with Tara Saunders who chairs BAFTAs Games Committee, and our deputy chairs Emily Stillman for Film, Christine Healy for TV and Des Gayle for Games, our committees play a central role in ensuring BAFTAs activities, including our world-leading awards, support and spotlight the screen industries and the talented people within them.

Biographies

Anna Higgs
Anna Higgs is managing director of Casarotto Ramsay & Associates, a fiercely independent agency for some of the worlds most exceptional talent working in film, theatre, television and new media. A creative leader with wide-ranging experience, she is also Chair of the BAFTA Film Committee and on the Board of Trustees. She has been named one ofTime OutsCreative 100 andCreative ReviewsCreative Leaders 50.

Emily Stillman
As senior vice president at Warner Bros. Studio Leavesden, Emily is responsible for Business Development, Marketing and Operations for Warner Bros. Studios Leavesden, Warner Bros. Leavesden Park and Warner Bros. Set Lighting & Rigging; working to attract all types of productions, from high-end TV drama to feature films, music videos and commercials. Most recently Emily oversaw the preparation and delivery of WBSL masterplan expansion application to local and central government, gaining approval on all levels with the construction plan due to start Jan 2024.
Emily is passionate about diversity and inclusion and during her time at Warner Bros. Studios Leavesden has worked on a number of initiatives and events with the aim of making the industry more inclusive, including an annual International Womens Day event.
Emily became a board member of the Production Guild in September 2020 and was elected to the BAFTA Film Committee in June 2021. She is also on the Film and TV charity Mental Health Taskforce Group, is a judge on the Movers and Shakers awards panel and was listed in Varietys Women That Have Made An Impact in Global Entertainment 2021 report.

Hilary Rosen
Hilary Rosen is director of commissioning at UKTV and leads UKTVs award-winning team of commissioners, overseeing all of UKTVs original unscripted and scripted content. Hilary has commissioned some of UKTVs biggest successes including BAFTA-winning show Taskmaster and award-winning Mel Giedroyc: Unforgivable. While running the Factual and Factual Entertainment slate she and her team commissioned breakout hits Emma Willis: Delivering Babies, Stacey Dooley Sleeps Over, the double BAFTA-winning Big Zuus Big Eats, Blackadder: The Lost Pilot and the Bangers and Cash franchise. Her team has delivered the hit scripted shows Annika, We Hunt Together and The Cockfields.
Prior to UKTV Hilary was creative director at Silver River. Her career has also encompassed ten years as a senior executive producer at Lion Television having begun her career in BBC News and Current Affairs at Panorama. Hilary is an active member of the BAFTA Television Committee and has also acted as a consultant for BBC Academy, worked on the Edinburgh International TV Festival and Realscreen advisories and is passionate about mentoring women in television.

Christine Healy
Christine is COO of Keshet Productions UK, a UK Scripted HETV production company, where she oversees the commercial, operational & production side of the business.
Throughout her television career she has played a pivotal role in the success of a multitude of high-profile dramas, including Line of Duty, Doctor Foster, The White Queen, Catherine the Great, and Des, and has worked with some of Britains leading production companies including New Pictures, Drama Republic, Leftbank, Company Pictures, World Productions, BBC Studios, and ITV Studios.
She remains an engaged Council member of the HETV Fund at ScreenSkills, whose main purpose is to support and enhance the HETV industry through professional training and development chiefly for below-the-line freelance talent at all stages of their careers across the whole of the UK.

Notes to Editors

A full list of Sector Committee and Board of Trustee members can be found atwww.bafta.org/about/key-personnel

About BAFTA

BAFTA the British Academy of Film and Television Arts – is a world-leading independent arts charity that brings the very best work in film, games and television to public attention and supports the growth of creative talent in the UK and internationally. Through its Awards ceremonies and year-round programme of learning events and initiatives which includes workshops, masterclasses, scholarships, lectures and mentoring schemes in the UK, USA and Asia BAFTA identifies and celebrates excellence, discovers, inspires and nurtures new talent, and enables learning and creative collaboration. For more, visit www.bafta.org. BAFTA is a registered charity (no. 216726).

PM chairs Video meeting of Governors, CMs and LGs to discuss aspects of India’s G20 Presidency

Dec 9, 2022 | Business

Prime Minister Shri Narendra Modi chaired a video meeting of the Governors and Chief Ministers of States and Lt Governors of Union Territories today, to discuss aspects relating to India’s G20 Presidency.

Prime Minister in his remarks stated that India’s G20 Presidency belongs to the entire nation, and is a unique opportunity to showcase the country’s strengths.

Prime Minister emphasized the importance of teamwork, and sought the cooperation of the States / UTs in the organization of various G20 events. He pointed out that the G20 Presidency would help showcase parts of India beyond the conventional big metros, thus bringing out the uniqueness of each part of our country.

Highlighting the large number of visitors who would be coming to India during India’s G20 Presidency and the international media focus on various events, Prime Minister underlined the importance of States and UTs utilizing this opportunity to rebrand themselves as attractive business, investment and tourism destinations. He also reiterated the need to ensure people’s participation in the G20 events by a whole-of-government and a whole-of-society approach.

A number of Governors, Chief Ministers, and Lt. Governors shared their thoughts during the meeting, emphasising the preparations being done by the states to suitably host G20 meetings.

The meeting was also addressed by External Affairs Minister, and a presentation was made by India’s G20 Sherpa.

***

DS/AK

(Release ID: 1882263)
Visitor Counter : 1423

Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy

Nov 12, 2022 | Business

Novotech, the leading Asia Pacific biotech specialist CRO, is sponsoring BioCentury-BayHelix East-West Summit 2022, and Novotech’s Chief Commercial Officer Barry Murphy is Session Chair for the expert panel on How to Build and Finance an East-West MRCT Strategy Workshop at the Summit (14-16 November 2022).

Novotech is sponsoring the Networking Reception and Dinner.

Workshop details:

Global Development Workshop: How to Build and Finance an East-West MRCT Strategy

November 15, 2022

2:30 PM – (PACIFIC TIME ZONE)

BioCentury-BayHelix East-West Summit 2022

https://conferences.biocentury.com/china-healthcare-summit/schedule

Panelists are:

– PATRICIA KEEGAN, M.D.: Chief Medical Officer, Junshi Biosciences

– KE LIU, M.D., PH.D.: Chief Development Officer, Marengo Therapeutics

– ROGER LUO, PH.D.: Chief Development Officer, Overland Pharmaceuticals

– PEONY YU, M.D.: Chief Medical Officer, Apollomics Inc.

Novotech has significant real-world experience in East-West MRCT strategy after more than 2 decades managing clinical research programs for biotechs across Asia Pacific and the US.

Commenting on Novotech’s experience, Chief Commercial Officer Barry Murphy said the right drug development pathway supports investor attraction and a successful clinical program.

“Local regulatory knowledge and expertise will accelerate early clinical programs, while a global perspective with a focus on US FDA and NMPA requirements, will support key market approvals. Strategies for an East-West MRCT include:

– Companies should engage with the US FDA and NMPA early to confirm guidance on their clinical roadmap.

– Biopharma companies should take advantage of China’s revised regulatory framework around acceptance of foreign clinical trials data for drug approval, making it easier for foreign companies to enter the Chinese market.

– For biopharma companies looking to enter China, China’s pharmaceutical market has advantages such as conducting first-in-human trials (FIH) and utilization of overseas clinical trial data for clinical trial application (CTA) filing, leveraging expedited clinical development pathways for accelerating the approval process; implementation of the Marketing Authorization Holder (MAH) system, favourable government policies to enhance domestic and global innovation encourages foreign direct investments (FDIs) in R&D that benefit the overseas companies.

Novotech regularly produces expert reports on East-West strategies. A new publication is now available for international biotechs considering China for their clinical research, as well as China biotechs conducting research in China.

The report details regulatory requirements for biotechs including NDA and IND processes as well as ex-US research guidance for a successful US FDA approval pathway. Download whitepaper here https://novotech-cro.com/whitepapers/china-biotech-landscape-opportunities-china-and-path-usfda-approval

Novotech, with experienced clinical teams in China and the US, can provide the relevant regulatory knowledge and drug development pathways specifically designed to support the US FDA and NMPA approval process, avoiding delays and additional costs.

Novotech has operations across the Asia Pacific and the US offering a unique and unparalleled suite of CRO services for early to late-phase biotech clinical research. The company has decades of biotech drug development experience, exceptional site and investigator relationships, access to vast patient populations, and a project management approach focused on problem-solving, ownership, and flexibility. Consistent investment in advanced training and technology systems combine to deliver a specialist full-service biotech CRO solution.

Novotech has recently been benchmarked as a top 10 CRO among the world’s leading CROs, is a finalist in the prestigious Scrip awards, and has just been awarded the Gene & Cell Therapy Excellence Award. In Asia Pacific Novotech has more than 50 Leading Site Partnership agreements with major medical research institutions which delivers exclusive benefits for sponsors.

About Novotech

Novotech is the leading Asia-Pacific biotech specialist CRO. Novotech has integrated labs and phase I facilities and provides drug development consulting and clinical development services across all phases. It has been instrumental in the success of approximately 4,000 clinical trials across a broad range of therapeutic areas. Novotech is well-positioned to serve biopharma clients conducting clinical trials in Asia-Pacific and the US. For more information visit https://novotech-cro.com/contact

Media Contact

communications@novotech-cro.com






Topic: Press release summary



PM chairs review meeting in Morbi

Nov 1, 2022 | Business


Prime Minister Shri Narendra Modi chaired a meeting in Morbi, Gujarat to review the situation in the wake of the unfortunate bridge mishap there.


Prime Minister said that the authorities must stay in touch with the affected families and ensure that they receive all possible help in this tragic hour.


Officials briefed the Prime Minister on the rescue ops and the assistance provided to those affected.


Prime Minister said the need of the hour is to conduct a detailed and extensive inquiry which will identify all aspects relating to this mishap. He also added that the key learnings from the inquiry must be implemented at the earliest. 



Those present at the meeting were CM Bhupendrabhai Patel, MoS Home Harsh Sanghavi, Minister in the Gujarat Government Brijesh Merja, Chief Secretary of Gujarat, State DGP, local Collector, SP,  Inspector General of Police, MLAs and MPs and other officials.


Earlier, upon reaching Morbi, the Prime Minister visited the site of the bridge mishap. He went to the local hospital where the injured are recovering. He also interacted with those involved in rescue and relief work and lauded their fortitude.


****


DS/ST




(Release ID: 1872769)
Visitor Counter : 559











Hong Kong – CE chairs 13th meeting of Commission on Children (with photo)

May 19, 2022 | International

CE chairs 13th meeting of Commission on Children (with photo)

*************************************************************


     The Chief Executive, Mrs Carrie Lam, chaired the 13th meeting of the Commission on Children today (May 19).



     A Commission on Children was established for the first time by the Government of the Hong Kong Special Administrative Region in fulfilment of the Chief Executive’s pledge in her Election Manifesto to consolidate the efforts made by relevant bureaux and departments and focus on addressing children’s issues as they grow up. Since June 2018, the Commission has been advising the Government in the formulation and implementation of various policies and programmes aiming at taking better care of children.



     Mrs Lam said, “While the Government has rolled out various initiatives in recent years, including strengthening the provision of child care services, expanding by phases the On-site Pre-school Rehabilitation Service to 10 000 places in the next school year in order to achieve the objective of ‘zero waiting’ time, introducing the Funding Scheme for Children’s Well-being and Development to support worthwhile projects, transforming more than 170 public play spaces to enhance the outdoor play environment for children, developing a central databank on children in Hong Kong to enable the Government and other stakeholders to collect and share useful data on children, etc., more need to be done as illustrated in the two subjects addressed by the Commission at this meeting.”



     During the meeting, members were briefed on:



(1) A comprehensive review of residential child care and related services to be conducted by the Government in the light of the incident in Children’s Residential Home of the Hong Kong Society for the Protection of Children which had aroused major public concern: The review would cover three major areas, namely service regulation and monitoring, service planning and provision and service quality and staff training. Members supported the review and offered views on major aspects that it should cover. The Government would complete the review in September 2022 and report the outcome to the Commission; and

    

(2) The fifth Report of the Child Fatality Review Panel and the Government’s responses

(www.swd.gov.hk/storage/asset/section/2867/en/CFRP_Fifth_Report_(Eng).pdf): Members noted that the review covered the death of 259 children aged below 18, 100 of whom were due to non-natural causes. The report revealed that most of the children who died of non-natural causes lost their lives because of suicide, followed by accidents. Members commended the work of the Review Panel and offered advice on possible ways to expand the coverage of the review and improve the timeliness in making recommendations. Members also supported the early implementation of the various recommendations made by the Review Panel to prevent child and youth deaths.

       

     Referring to the proverb that “it takes a village to raise a child”, Mrs Lam said that protection of children should be the priority and obligation of not only the Government, but also all service providers, principals and teachers, and most importantly, parents.



     “To raise alertness and ensure that each party will do its best, I said in my 2021 Policy Address that we would take forward legislation on establishing a mandatory reporting mechanism of child abuse. The Labour and Welfare Bureau is aiming at introducing a Bill into the Legislative Council in the first half of 2023,” she added.



     Members noted the Government’s efforts to stabilise the epidemic while upholding the pro-child and pro-family principle. For cases where children were involved, the Government had been striving to ensure that each and every decision was made in the interests of the children and their families. Separation of children and parents during hospitalisation or quarantine should be avoided, and specific needs of the affected children should be fully taken into account.



     Mrs Lam said, “I express my sincere gratitude to the Commission for its dedication over the years and members’ initiative of presenting proposals on how to strengthen care for the child at this meeting. We will make sure that their views are conveyed to the next-term Chief Executive for consideration.”



     Members extended their heartfelt appreciation to the Chief Executive for her staunch support in the establishment of the Commission and the importance she attached to safeguarding the rights, interests and well-being of children.



     The chairperson of the Commission is the Chief Secretary for Administration. As the post of the Chief Secretary for Administration has been left vacant, the meeting today was chaired by the Chief Executive.